3DPOD Episode 175: 3D Printed Cartilage Implants with Ben Holmes, Nanochon CEO
Ben Holmes shares his venture into developing a potentially game-changing medical device technology. His company, Nanochon, aims to alleviate cartilage problems with an implant that initially substitutes the cartilage, then fosters natural body repair. Given that cartilage issues plague millions, this innovation holds promise for being both lucrative and impactful. Conditions like osteoarthritis significantly impair the quality of life for many. This narrative delves into the creation of the product and the ongoing journey of the startup. It’s important to note: Nanochon’s Chondrograft device has yet to receive approval for use in the United States.
Podcast (podcast-audio): Play in new window | Download
Subscribe to Our Email Newsletter
Stay up-to-date on all the latest news from the 3D printing industry and receive information and offers from third party vendors.
Print Services
Upload your 3D Models and get them printed quickly and efficiently.
You May Also Like
AM Asia Watch: China’s HeyGears Lands $44M to Expand Beyond Dental 3D Printing
Chinese 3D printing company HeyGears raised more than 300 million Yuan (roughly $44 million) in a new Series C funding round as it looks to expand beyond its industrial and...
The University of Utrecht: “3D Printing Could Change Who Gets to Become a Manufacturing Power”
For decades, manufacturing has mostly been controlled by countries with huge factories, lower labor costs, and industrial systems that took years, sometimes decades, to build. But Utrecht University human geographers...
3D Printing News Briefs, May 28, 2026: Continuous Fiber Reinforcement, Bioprinted Trachea, & More
In today’s 3D Printing News Briefs, America Makes announced the winners of its JAQS-SQ Project Call. Axtra3D is partnering with Keystone Industries to expand its dental material ecosystem, while BigRep...
Asia AM Watch: China’s SHINING 3D Restarts IPO Review Process
SHINING 3D is moving forward again with its plans to go public in China, after restarting its Beijing Stock Exchange (BSE) initial public offering (IPO) review process and filing updated...
